A total dosage of ACM was refractory ALL or CML in complete remission, which suggests no cross-resistance between ACM and DNR. PR 40% (10/ 25). NR 16% (4/25).

• 结果:CR44%25(11/25),CR中4例(ALL2例,CML2例)为复治病例,表明安乐霉素与柔红霉素无交叉耐药性,PR40%25(10/25),NR16%25(4/25)。